CVS Health Co. (NYSE:CVS) Shares Acquired by OneAscent Financial Services LLC

OneAscent Financial Services LLC increased its position in CVS Health Co. (NYSE:CVS) by 22.7% in the fourth quarter, Holdings Channel reports. The firm owned 6,027 shares of the pharmacy operator’s stock after purchasing an additional 1,117 shares during the quarter. OneAscent Financial Services LLC’s holdings in CVS Health were worth $271,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ridgewood Investments LLC increased its holdings in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 450 shares during the last quarter. Stonebridge Financial Group LLC bought a new stake in CVS Health during the fourth quarter valued at $28,000. Hopwood Financial Services Inc. bought a new position in shares of CVS Health in the 4th quarter worth about $29,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the 3rd quarter valued at about $31,000. Finally, Financial Perspectives Inc raised its stake in CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock worth $36,000 after acquiring an additional 466 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Buying and Selling

In other CVS Health news, SVP James David Clark sold 7,513 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company’s stock, valued at $556,941.90. The trade was a 47.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael F. Mahoney bought 30,000 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The stock was acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.24% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. StockNews.com raised CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, February 13th. JPMorgan Chase & Co. raised their target price on CVS Health from $80.00 to $81.00 and gave the company an “overweight” rating in a research note on Tuesday, February 18th. Argus set a $77.00 price target on shares of CVS Health in a research report on Tuesday, February 18th. Wells Fargo & Company boosted their target price on shares of CVS Health from $68.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Finally, Barclays raised their price target on shares of CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $70.39.

CVS Health Price Performance

Shares of NYSE CVS opened at $63.54 on Friday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $75.12. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a 50-day moving average of $63.47 and a two-hundred day moving average of $58.01. The company has a market capitalization of $80.11 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be given a $0.665 dividend. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.19%. CVS Health’s dividend payout ratio (DPR) is 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.